BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10435639)

  • 1. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
    Rouer E; Brule F; Benarous R
    Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare mRNA variant of the human lymphocyte-specific protein tyrosine kinase LCK gene with intron B retention and exon 7 skipping encodes a putative protein with altered SH3-dependent molecular interactions.
    Nervi S; Guinamard R; Delaval B; Lécine P; Vialettes B; Naquet P; Imbert J
    Gene; 2005 Oct; 359():18-25. PubMed ID: 16107303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs.
    Gruber C; Henkel M; Budach W; Belka C; Jendrossek V
    Biochem Pharmacol; 2004 May; 67(10):1859-72. PubMed ID: 15130763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The exon 7-spliced Lck isoform in T lymphocytes: a potential regulator of p56lck signaling pathways.
    Germani A; Malherbe S; Rouer E
    Biochem Biophys Res Commun; 2003 Feb; 301(3):680-5. PubMed ID: 12565834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential nucleotides direct neuron-specific splicing of gamma 2 pre-mRNA.
    Zhang L; Ashiya M; Sherman TG; Grabowski PJ
    RNA; 1996 Jul; 2(7):682-98. PubMed ID: 8756411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing in the human lck gene leads to the deletion of exon 1' and results in a new type II lck transcript.
    Rouer E; Benarous R
    Oncogene; 1992 Dec; 7(12):2535-8. PubMed ID: 1461657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective RNA splicing resulting from a mutation in the cyclic guanosine monophosphate-phosphodiesterase beta-subunit gene.
    Piriev NI; Shih JM; Farber DB
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):463-70. PubMed ID: 9501854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lck tyrosine kinase is important for activation of the CD11a/CD18-integrins in human T lymphocytes.
    Fagerholm S; Hilden TJ; Gahmberg CG
    Eur J Immunol; 2002 Jun; 32(6):1670-8. PubMed ID: 12115650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease.
    Di Leo E; Panico F; Tarugi P; Battisti C; Federico A; Calandra S
    Hum Mutat; 2004 Nov; 24(5):440. PubMed ID: 15459971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL; Homer VM; George PM; Brennan SO
    Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
    Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
    Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure function analysis of SH2D2A isoforms expressed in T cells reveals a crucial role for the proline rich region encoded by SH2D2A exon 7.
    Granum S; Sundvold-Gjerstad V; Dai KZ; Kolltveit KM; Hildebrand K; Huitfeldt HS; Lea T; Spurkland A
    BMC Immunol; 2006 Jul; 7():15. PubMed ID: 16839418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel single-base substitution (380C>T) that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene.
    Nakamura K; Fukao T; Perez-Cerda C; Luque C; Song XQ; Naiki Y; Kohno Y; Ugarte M; Kondo N
    Mol Genet Metab; 2001 Feb; 72(2):115-21. PubMed ID: 11161837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of human acatalasemia. Identification of a splicing mutation.
    Wen JK; Osumi T; Hashimoto T; Ogata M
    J Mol Biol; 1990 Jan; 211(2):383-93. PubMed ID: 2308162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells.
    Wu J; Cheng Y; Nilsson A; Duan RD
    Carcinogenesis; 2004 Aug; 25(8):1327-33. PubMed ID: 15016655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.